Maharashtra FDA minister to hear on Thursday J&J's appeal on cancellation of licence

Fate of Jhonson & Jhonson's licence depends on the outcome of Thursday's hearing

Maharashtra’s food and drug administration minister will hear on Thursday an appeal by Johnson & Johnson (J&J) against state Food and Drug Administration (FDA)’s move to cancel the company’s in April. The fate of the depends on the outcome of Thursday’s hearing.

had issued the cancellation order on March 30 and J&J was given 90 days (up to June) to plead its case before the state. J&J’s for cosmetics at Mulund plant was cancelled by FDA, which expressed concerns over the ethylene oxide used during sterilisation that aimed to bring down microbial load in the same batch of baby powder produced in 2007.

FDA's had cancelled Johnson & Johnson India’s to manufacture cosmetics at its facility in Mulund, a Mumbai suburb.

Thursday's hearing was confirmed by both the office of Naik and Commissioner Mahesh Zagde.  Zagde told Business Standard "Any action taken by licensing authority can be appealed to the state government. J&J has done so." However, J&J spokesman declined to comment.

It must be mentioned here that FDA's action was related to  a few batches of baby powder produced in 2007, the shelf life of which ended in July 2010. had expressed concern over use of ethylene oxide for sterilization to bring down the microbial load.

had said that the company did not conduct the mandatory test to ensure absence of traces of ethylene oxide, a carcinogenic substance before release of these batches. Since it was used in a product meant for infants, observed, it was more objectionable. had noted that  the company had carried out sterilization of 15 batches (of 160,000 retail containers) of baby powder by using ethylene oxide, against the normal practice of steam sterilization.

image
Business Standard
177 22
Business Standard

Maharashtra FDA minister to hear on Thursday J&J's appeal on cancellation of licence

Fate of Jhonson & Jhonson's licence depends on the outcome of Thursday's hearing

Sanjay Jog  |  Mumbai 

Maharashtra’s food and drug administration minister will hear on Thursday an appeal by Johnson & Johnson (J&J) against state Food and Drug Administration (FDA)’s move to cancel the company’s in April. The fate of the depends on the outcome of Thursday’s hearing.

had issued the cancellation order on March 30 and J&J was given 90 days (up to June) to plead its case before the state. J&J’s for cosmetics at Mulund plant was cancelled by FDA, which expressed concerns over the ethylene oxide used during sterilisation that aimed to bring down microbial load in the same batch of baby powder produced in 2007.



FDA's had cancelled Johnson & Johnson India’s to manufacture cosmetics at its facility in Mulund, a Mumbai suburb.

Thursday's hearing was confirmed by both the office of Naik and Commissioner Mahesh Zagde.  Zagde told Business Standard "Any action taken by licensing authority can be appealed to the state government. J&J has done so." However, J&J spokesman declined to comment.

It must be mentioned here that FDA's action was related to  a few batches of baby powder produced in 2007, the shelf life of which ended in July 2010. had expressed concern over use of ethylene oxide for sterilization to bring down the microbial load.

had said that the company did not conduct the mandatory test to ensure absence of traces of ethylene oxide, a carcinogenic substance before release of these batches. Since it was used in a product meant for infants, observed, it was more objectionable. had noted that  the company had carried out sterilization of 15 batches (of 160,000 retail containers) of baby powder by using ethylene oxide, against the normal practice of steam sterilization.

RECOMMENDED FOR YOU

Maharashtra FDA minister to hear on Thursday J&J's appeal on cancellation of licence

Fate of Jhonson & Jhonson's licence depends on the outcome of Thursday's hearing

Fate of Jhonson & Jhonson's licence depends on the outcome of Thursday's hearing Maharashtra’s food and drug administration minister will hear on Thursday an appeal by Johnson & Johnson (J&J) against state Food and Drug Administration (FDA)’s move to cancel the company’s in April. The fate of the depends on the outcome of Thursday’s hearing.

had issued the cancellation order on March 30 and J&J was given 90 days (up to June) to plead its case before the state. J&J’s for cosmetics at Mulund plant was cancelled by FDA, which expressed concerns over the ethylene oxide used during sterilisation that aimed to bring down microbial load in the same batch of baby powder produced in 2007.

FDA's had cancelled Johnson & Johnson India’s to manufacture cosmetics at its facility in Mulund, a Mumbai suburb.

Thursday's hearing was confirmed by both the office of Naik and Commissioner Mahesh Zagde.  Zagde told Business Standard "Any action taken by licensing authority can be appealed to the state government. J&J has done so." However, J&J spokesman declined to comment.

It must be mentioned here that FDA's action was related to  a few batches of baby powder produced in 2007, the shelf life of which ended in July 2010. had expressed concern over use of ethylene oxide for sterilization to bring down the microbial load.

had said that the company did not conduct the mandatory test to ensure absence of traces of ethylene oxide, a carcinogenic substance before release of these batches. Since it was used in a product meant for infants, observed, it was more objectionable. had noted that  the company had carried out sterilization of 15 batches (of 160,000 retail containers) of baby powder by using ethylene oxide, against the normal practice of steam sterilization.
image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard